Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Supports healthy insulin response
selective antagonist co-treatment designs
13, the ROS scavenging ratio of G/D-CuP exceeded 95% at different concentrations, indicating a potential beneficial antioxidant effect for treating diabetic wounds
Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP [PMID: 223632] Laboratory literature summary: Cosubstrate and allosteric modifier activities of structural analogues of NAD and ADP for NAD-specific isocitrate dehydrogenase from
Diabetologia 63(2):221228
US$ 29.82
US$ 26.43
US$ 24.10
US$ 24.75
